Navigation Links
Covance Recognized for Outstanding Performance by Merck & Co., Inc.

PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, today announced that its central laboratory services received Merck & Co., Inc.'s Outstanding Strategic Collaboration Award.

Covance Central Laboratory Services is one of only 12 suppliers who were selected from thousands of Merck suppliers. The criteria for receiving this award included scorecard performance; contributions towards the Key Business Result (KBR) for Merck; Covance's ability to work with niche suppliers to further Merck's business; and operational excellence. Covance received the award at Merck's annual Supplier Recognition Forum.

"Our strategy of operational and service excellence is critical to our success. We are proud of our Merck team for delivering on this strategy and of the work that we all have done with Merck as well as the positive impact it has had on human lives," said Deborah Tanner, President of Covance Central Laboratory Services and Senior Vice President of Covance Inc. "We are honored to be recognized for the collaborative spirit, innovation, expertise, experience, and integrity we bring to our partnerships."

Covance is the most experienced central laboratory services provider in the world. Since 1986, it has focused solely on clinical trials. In the past five years alone, it has performed more than 150 million tests; provided services for more than 3,000 clinical trial protocols; and supported nearly 100,000 investigator sites in 100 countries. It maintains wholly-owned central laboratories in Indianapolis, Indiana; Geneva, Switzerland; Singapore; and Shanghai, China.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and nearly 9,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at

SOURCE Covance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
2. Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call
3. Covance to Present at the William Blair Growth Stock Conference
4. Covance Elects Joseph C. Scodari to Companys Board of Directors
5. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
6. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
7. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
8. Covance to Present at UBS Global Healthcare Services Conference
9. Covance to Present at 26th Annual JPMorgan Healthcare Conference
10. Wendel Barr Appointed Chief Operating Officer of Covance
11. Covance and Care Partner on Rwanda Early Childhood Development Initiative
Post Your Comments:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: